Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The investigators conducted a randomized trial to study how well multi-day methotrexate
protocol works compared to biweekly single-dose actinomycin D protocol in treating patients
with low-risk gestational trophoblastic neoplasia. It is not yet known whether multi-day
methotrexate protocol is as effective as biweekly single-dose actinomycin D protocol in
treating patients with gestational trophoblastic neoplasia.